TD Cowen reaffirmed its positive long-term view on Microsoft while trimming its 12-month price target from $655 to $625. The firm cited stable to strengthening demand for GPU and CPU infrastructure based on recent channel checks, supporting expectations that enterprise and cloud customers continue to invest heavily in AI workloads. Ahead of the fiscal second-quarter earnings report on January 28, the analyst noted that potential upside from Azure’s constant-currency growth (roughly two percentage points above current estimates) may be offset by capacity constraints, which could limit acceleration in the coming quarters.

In its most recent quarter, Microsoft’s cloud-computing segment grew 40% year-over-year, outperforming the broader revenue increase of 18%. The Productivity and Business Processes division—home to Office 365 and Dynamics—posted 17% revenue growth, reflecting incremental price increases tied to new AI integrations. Capital expenditures in the period totaled $80 billion, reflecting an $80 billion multiyear commitment to data-center build-out. Management guided for similar cloud growth rates in the upcoming quarter and plans to double its global data-center footprint over the next two years to meet surging AI infrastructure demand.

Microsoft has teamed up with Bristol Myers Squibb to deploy FDA-cleared AI radiology algorithms through the Precision Imaging Network, which covers over 80% of U.S. hospitals. The collaboration will apply automated analysis to X-ray and CT scans to improve early detection of lung nodules and reduce clinical workload, with a special focus on rural and medically underserved communities. By integrating workflow tools that track incidental findings and guide patients to follow-up care, the platform aims to address the fact that more than half of patients with incidental lung findings are currently lost to follow-up.

Elon Musk’s lawsuit against OpenAI and Microsoft alleges damages between $79 billion and $134 billion; however, Microsoft’s maximum exposure is estimated at approximately $25 billion and is fully covered by its $102 billion in cash and marketable securities. Analysts view the legal risk as manageable relative to the company’s liquidity. Microsoft currently trades at about 28.3 times expected 2026 earnings, with consensus forecasting roughly 19.2% EPS growth next year—metrics that sit near the low end of its historical valuation range, suggesting limited downside while positioning for upside if legal proceedings resolve favorably.